Nevertheless, abnormalities in the mTOR-dependent signalling pathway have been suggested in the pathology of several disorders, from neurodevelopmental syndromes in which autism is highly prevalent, to neurodegenerative disorders such as Alzheimer’s disease (AD) and Parkinson’s disease (PD) [12,13,14]. This evidence concerns the gene MTOR and autism.